BNP Paribas Financial Markets’s Albireo Pharma, Inc. Common Stock ALBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-3,334
| Closed | -$72K | – | 3375 |
|
|
2022
Q4 | $72K | Sell |
3,334
-10,506
| -76% | -$227K | ﹤0.01% | 2680 |
|
|
2022
Q3 | $268K | Buy |
13,840
+7,338
| +113% | +$142K | ﹤0.01% | 2666 |
|
|
2022
Q2 | $129K | Buy |
6,502
+2,997
| +86% | +$59.5K | ﹤0.01% | 2637 |
|
|
2022
Q1 | $105K | Sell |
3,505
-2,096
| -37% | -$62.5K | ﹤0.01% | 2784 |
|
|
2021
Q4 | $130K | Sell |
5,601
-1,327
| -19% | -$30.9K | ﹤0.01% | 2880 |
|
|
2021
Q3 | $216K | Buy |
6,928
+1,843
| +36% | +$57.5K | ﹤0.01% | 2430 |
|
|
2021
Q2 | $179K | Sell |
5,085
-4,307
| -46% | -$152K | ﹤0.01% | 2312 |
|
|
2021
Q1 | $331K | Buy |
9,392
+7,148
| +319% | +$252K | ﹤0.01% | 2259 |
|
|
2020
Q4 | $84.2K | Sell |
2,244
-1,196
| -35% | -$44.9K | ﹤0.01% | 2648 |
|
|
2020
Q3 | $115K | Buy |
3,440
+2,220
| +182% | +$74.1K | ﹤0.01% | 2432 |
|
|
2020
Q2 | $32.3K | Sell |
1,220
-3,293
| -73% | -$87.2K | ﹤0.01% | 2585 |
|
|
2020
Q1 | $73.9K | Buy |
4,513
+3,004
| +199% | +$49.2K | ﹤0.01% | 2749 |
|
|
2019
Q4 | $38.4K | Sell |
1,509
-24
| -2% | -$610 | ﹤0.01% | 3126 |
|
|
2019
Q3 | $30.7K | Buy |
1,533
+508
| +50% | +$10.2K | ﹤0.01% | 3108 |
|
|
2019
Q2 | $33K | Sell |
1,025
-872
| -46% | -$28.1K | ﹤0.01% | 3048 |
|
|
2019
Q1 | $61.1K | Buy |
1,897
+1,697
| +849% | +$54.7K | ﹤0.01% | 2811 |
|
|
2018
Q4 | $4.91K | Sell |
200
-98
| -33% | -$2.4K | ﹤0.01% | 2918 |
|
|
2018
Q3 | $9.82K | Sell |
298
-2
| -0.7% | -$66 | ﹤0.01% | 3073 |
|
|
2018
Q2 | $10.7K | Buy |
+300
| New | +$10.7K | ﹤0.01% | 3098 |
|